PIGV and hyperphosphatemia: HPMRS-1 is currently also known as GPIBD2 or PIGV-congenital disorder of glycosylation (PIGV-CDG), due to its difference in terms of phenotype from the typical clinical image of GPIBDs which derives from its alterations of alkalic phosphatase (ALP) activity and consecutive hyperphosphatemia.